HIZYME Trademark

Trademark Overview


On Thursday, January 11, 2024, a trademark application was filed for HIZYME with the United States Patent and Trademark Office. The USPTO has given the HIZYME trademark a serial number of 79393093. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, August 20, 2024. This trademark is owned by BIONUTRI PTE. LTD.. The HIZYME trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical purposes; chemical preparations containing enzymes for veterinary purposes; coenzyme Q10 dietary supplements; digestive enzymes for medical purposes; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzyme supplements for medical purposes; enzymes for medical or veterinary use; enzymes for medical purposes; enzymes for veterinary purposes; pepsin [enzymes] for veterinary purposes; preparations of enzymes for medical purposes; pharmaceutical preparations containing enzymes; preparations of enzymes for veterinary purposes; purified enzymes for veterinary use; purified enzymes for medical use; reagents in kit form for conducting enzyme-linked immunosorbent assays [ELISA] for medical purposes; reagents in kit form for conducting enzyme-linked immunosorbent assays [ELISA] for veterinary purposes; recombin...
hizyme

General Information


Serial Number79393093
Word MarkHIZYME
Filing DateThursday, January 11, 2024
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical purposes; chemical preparations containing enzymes for veterinary purposes; coenzyme Q10 dietary supplements; digestive enzymes for medical purposes; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzyme supplements for medical purposes; enzymes for medical or veterinary use; enzymes for medical purposes; enzymes for veterinary purposes; pepsin [enzymes] for veterinary purposes; preparations of enzymes for medical purposes; pharmaceutical preparations containing enzymes; preparations of enzymes for veterinary purposes; purified enzymes for veterinary use; purified enzymes for medical use; reagents in kit form for conducting enzyme-linked immunosorbent assays [ELISA] for medical purposes; reagents in kit form for conducting enzyme-linked immunosorbent assays [ELISA] for veterinary purposes; recombinant human drug-metabolizing enzyme being biochemical preparations for medical purposes; recombinant human enzyme being biochemical preparations for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIONUTRI PTE. LTD.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Trademark Events


Event DateEvent Description
Friday, April 12, 2024APPLICATION FILING RECEIPT MAILED
Monday, August 12, 2024NON-FINAL ACTION WRITTEN
Thursday, April 4, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 7, 2024ASSIGNED TO EXAMINER
Tuesday, August 13, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 20, 2024NON-FINAL ACTION WRITTEN
Tuesday, August 20, 2024NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW